197 related articles for article (PubMed ID: 1150857)
1. Dissociated responses of plasma testosterone and estradiol to human chorionic gonadotropin in adult men.
Mahoudeau JA; Valcke JC; Bricaire H
J Clin Endocrinol Metab; 1975 Jul; 41(1):13-20. PubMed ID: 1150857
[TBL] [Abstract][Full Text] [Related]
2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
3. Plasma testosterone, estradiol, progesterone and 17-hydroxy-progesterone responses to single-dose stimulation with human chorionic gonadotropin in chronic male alcoholics.
Gatti G; Bertello P; Gurioli L; Pinna G; Berruti A; De Micheli AG; Angeli A
J Endocrinol Invest; 1985 Aug; 8(4):313-9. PubMed ID: 4067203
[TBL] [Abstract][Full Text] [Related]
4. Response to a single dose of human chorionic gonadotropin in prepubertal boys.
Toscano V; Balducci R; Adamo MV; Manca Bitti ML; Sciarra F; Boscherini B
J Clin Endocrinol Metab; 1983 Aug; 57(2):421-4. PubMed ID: 6863482
[TBL] [Abstract][Full Text] [Related]
5. Single versus repeated dose human chorionic gonadotropin stimulation in the differential diagnosis of hypogonadotropic hypogonadism.
Dunkel L; Perheentupa J; Sorva R
J Clin Endocrinol Metab; 1985 Feb; 60(2):333-7. PubMed ID: 3965492
[TBL] [Abstract][Full Text] [Related]
6. Testicular steroidogenesis in adult men with human chorionic gonadotropin-producing tumors.
Rieu M; Reznik Y; Vannetzel JM; Mahoudeau J; Berrod JL; Kuhn JM
J Clin Endocrinol Metab; 1995 Aug; 80(8):2404-9. PubMed ID: 7629236
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of the human chorionic gonadotropin stimulation test in hypogonadal males.
Kelly WF; Kjeld JM; Mashiter K; Joplin GF
Arch Androl; 1982 Feb; 8(1):53-9. PubMed ID: 7065782
[TBL] [Abstract][Full Text] [Related]
8. Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test.
Meier C; Christ-Crain M; Christoffel-Courtin C; Staub JJ; Müller B
Clin Lab; 2005; 51(9-10):509-15. PubMed ID: 16285473
[TBL] [Abstract][Full Text] [Related]
9. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
10. Sex hormone-binding globulin changes with androgen replacement.
Plymate SR; Leonard JM; Paulsen CA; Fariss BL; Karpas AE
J Clin Endocrinol Metab; 1983 Sep; 57(3):645-8. PubMed ID: 6683724
[TBL] [Abstract][Full Text] [Related]
11. Leydig cell responsiveness to single and repeated human chorionic gonadotropin administration.
Smals AG; Pieters GF; Drayer JI; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1979 Jul; 49(1):12-4. PubMed ID: 447810
[TBL] [Abstract][Full Text] [Related]
12. Plasma estradiol concentrations and effect of HCG on plasma estradiol and testosterone in normal subjects and patients with endocrine disorders.
Ishimaru T
Endocrinol Jpn; 1975 Aug; 22(4):287-96. PubMed ID: 1201738
[TBL] [Abstract][Full Text] [Related]
13. [Response of male hypogonadotropic hypogonadism to long-term hCG treatment].
Shi YF; Chen DL; Wu QY
Zhonghua Nei Ke Za Zhi; 1987 Oct; 26(10):590-4, 622. PubMed ID: 3436229
[No Abstract] [Full Text] [Related]
14. Testicular responsiveness following chronic administration of hCG (1500 IU every six days) in untreated hypogonadotropic hypogonadism.
Balducci R; Toscano V; Casilli D; Maroder M; Sciarra F; Boscherini B
Horm Metab Res; 1987 May; 19(5):216-21. PubMed ID: 3583230
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulpiride induced hyperprolactinemia on testosterone secretion and metabolism before and after HCG in normal men.
Bernini GP; Gasperi M; Franchi F; Luisi M
J Endocrinol Invest; 1983 Aug; 6(4):287-91. PubMed ID: 6643949
[TBL] [Abstract][Full Text] [Related]
16. Testicular responsiveness to chronic human chorionic gonadotropin administration in hypogonadotropic hypogonadism.
D'Agata R; Vicari E; Aliffi A; Maugeri G; Mongioì A; Gulizia S
J Clin Endocrinol Metab; 1982 Jul; 55(1):76-80. PubMed ID: 6210708
[TBL] [Abstract][Full Text] [Related]
17. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
Guo CY; Jones TH; Eastell R
J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
[TBL] [Abstract][Full Text] [Related]
18. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
[TBL] [Abstract][Full Text] [Related]
19. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
[TBL] [Abstract][Full Text] [Related]
20. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
Bagatell CJ; Dahl KD; Bremner WJ
J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
